Significance of Primary Tumor Size and Preorchiectomy Serum Tumor Marker Level in Predicting Pathologic Stage at Retroperitoneal Lymph Node Dissection in Clinical Stage A Nonseminomatous Germ Cell Tumors
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prospective metastatic risk assignment in clinical stage I nonseminomatous germ cell testis cancer: a single institution pilot study☆Urologic Oncology: Seminars and Original Investigations, 2004
- Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testisUrology, 2004
- Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group TrialJournal of Clinical Oncology, 2003
- Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled AnalysisJournal of Clinical Oncology, 2002
- Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment.Journal of Clinical Oncology, 1998
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Identifying patients with low risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillanceUrology, 1989